Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Celecoxib may help relieve moderate or severe pain associated with cancer. It may
also decrease weight loss and improve muscle strength in cancer patients.
PURPOSE: This randomized clinical trial is studying celecoxib to see how well it works in
managing pain, weight loss, and weakness in patients with advanced cancer.